Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Biodesix, Inc. - Common Stock (NQ:BDSX)

14.44 -0.09 (-0.65%)
Streaming Delayed Price Updated: 1:20 PM EDT, Apr 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 20,612
Open 14.80
Bid (Size) 14.28 (100)
Ask (Size) 14.79 (100)
Prev. Close 14.53
Today's Range 14.15 - 14.98
52wk Range 0.1718 - 20.21
Shares Outstanding 78,614,114
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development
Includes novel proteomic and genomic approaches to oncology therapeutic selection, response monitoring, and Molecular Residual Disease (MRD) testing 
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix Announces the Largest Lung Nodule Biomarker Clinical Validation Study Ever Published Supporting Earlier Lung Cancer Diagnosis
A retrospective pooled analysis of 1,100 patients demonstrates the Nodify CDT® test’s consistent clinical performance across nodule sizes and patient populations 
From Biodesix, Inc.
Via GlobeNewswire

Performance

YTD
+123.5%
+123.5%
1 Month
-25.6%
-25.6%
3 Month
+139.4%
+139.4%
6 Month
+97.7%
+97.7%
1 Year
+2392.2%
+2392.2%

More News

Read More
News headline image
Biodesix (BDSX) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Biodesix Inc (NASDAQ:BDSX) Reports Q4 2025 Earnings Beat and First Adjusted EBITDA Profitability ↗
Via Chartmill
Topics Earnings
BDSX Stock Shot Up 23% Pre-Market Today — What’s Fueling The Surge? ↗
Via Stocktwits
News headline image
Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix to Participate in Upcoming Investor Conferences
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
From Biodesix, Inc.
Via GlobeNewswire
Which stocks are moving on Wednesday? ↗
Via Chartmill
News headline image
Earnings Scheduled For November 3, 2025 ↗
Via Benzinga
News headline image
What's Next: Biodesix's Earnings Preview ↗
Via Benzinga
Curious about the stocks that are showing activity after the closing bell on Monday? ↗
Via Chartmill
News headline image
Biodesix Shares Rocket 42% on Record FY2025 Results and Path to Profitability
Via MarketMinute
Topics Artificial Intelligence Death
News headline image
Biodesix Announces Preliminary Fourth Quarter and Full-Year 2025 Results (Unaudited)
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix to Present New Data at Two Major Upcoming Scientific Meetings
From Biodesix, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Via Benzinga
News headline image
Biodesix Announces Third Quarter 2025 Results and Highlights
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting
From Biodesix, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Via Benzinga
News headline image
Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix to Report Third Quarter 2025 Financial Results on November 3, 2025
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix Unveils October Lung Health Events in Colorado with the Association of Pulmonary Advanced Practice Providers (APAPP), American Lung Association in Colorado, and GO2 for Lung Cancer Centers of Excellence Summit
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Monday's pre-market session: top gainers and losers ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Via Benzinga

Frequently Asked Questions

Is Biodesix, Inc. - Common Stock publicly traded?
Yes, Biodesix, Inc. - Common Stock is publicly traded.
What exchange does Biodesix, Inc. - Common Stock trade on?
Biodesix, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Biodesix, Inc. - Common Stock?
The ticker symbol for Biodesix, Inc. - Common Stock is BDSX on the Nasdaq Stock Market
What is the current price of Biodesix, Inc. - Common Stock?
The current price of Biodesix, Inc. - Common Stock is 14.44
When was Biodesix, Inc. - Common Stock last traded?
The last trade of Biodesix, Inc. - Common Stock was at 04/08/26 01:20 PM ET
What is the market capitalization of Biodesix, Inc. - Common Stock?
The market capitalization of Biodesix, Inc. - Common Stock is 1.13B
How many shares of Biodesix, Inc. - Common Stock are outstanding?
Biodesix, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.